Biohaven Ltd. (BHVN) Financials

BHVN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 382.7 million 92.7 million
2023-06-30 506.7 million 119.5 million
2023-03-31 618.5 million 146.3 million
2022-12-31 661.8 million 123.0 million

BHVN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -96.1 million 4.5 million
2023-06-30 -45.0 million 4.7 million
2023-03-31 -78.4 million 3.8 million
2022-12-31 -75.7 million 115.6 million

BHVN Net Income

No data available :(

BHVN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 240.6 million - 31.6 million
2023-06-30 335.1 million - 29.1 million
2023-03-31 388.0 million - 29.8 million
2022-12-31 465.3 million - 30.6 million

BHVN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 68.3 million
2023-06-30 68.2 million
2023-03-31 68.2 million
2022-12-31 60.9 million

BHVN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 1.2 million 95.5 million 15.0 million -
2023-06-30 595000 79.5 million 14.5 million -
2023-03-31 735000 63.5 million 14.3 million -
2022-12-31 300000 137.0 million 76.4 million -

BHVN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 857000
2023-06-30 - 800000
2023-03-31 - 764000
2022-12-31 -215.1 million 35.7 million

BHVN

Price: $40.69

52 week price:
12.35
62.21

Earnings Per Share: -5.73 USD

P/E Ratio: -6.15

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Volume: 704100

Ebitda: -42.6 million

Market Capitalization: 4.3 billion

Links: